Mark McMillan
Impact in
- Microbiology top 0.5%
- Bacterial Infections and Vaccines
- Reproductive tract infections research
- Health top 5%
- Vaccine Coverage and Hesitancy
Papers in
- Microbiology 25
- Bacterial Infections and Vaccines 24
- Epidemiology 14
- Influenza Virus Research Studies 10
- Respiratory viral infections research 5
- Pneumonia and Respiratory Infections 3
- Co-authors
- Helen Marshall (37 shared papers)Debbie Kralik (4 shared papers)Kylie Porritt (4 shared papers)Thomas Sullivan (9 shared papers)Ross Andrews (4 shared papers)Bing Wang (9 shared papers)Joshua S. Davis (3 shared papers)Nicholas M. Anstey (3 shared papers)
- Journals
- Human Vaccines & Immunotherapeutics (5 papers)Vaccine (5 papers)Clinical Infectious Diseases (4 papers)BMJ Open (3 papers)Journal of Infection (3 papers)
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Mark McMillan
46 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 99
- Microbiology 449
- Health 164
- Obstetrics and Gynecology 113
- Epidemiology 493
- Applied Microbiology and Biotechnology 23
Countries citing papers authored by Mark McMillan
This map shows the geographic impact of Mark McMillan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark McMillan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark McMillan more than expected).
Fields of papers citing papers by Mark McMillan
This network shows the impact of papers produced by Mark McMillan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark McMillan. The network helps show where Mark McMillan may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark McMillan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 129 | |
| 2 | 2016 | 117 | |
| 3 | 2015 | 107 | |
| 4 | 2016 | 85 | |
| 5 | 2016 | 68 | |
| 6 | 2017 | 67 | |
| 7 | 2011 | 66 | |
| 8 | 2022 | 61 | |
| 9 | 2009 | 53 | |
| 10 | 2014 | 46 | |
| 11 | 2020 | 43 | |
| 12 | 2023 | 39 | |
| 13 | 2019 | 35 | |
| 14 | 2019 | 28 | |
| 15 | 2023 | 26 | |
| 16 | 2020 | 25 | |
| 17 | 2018 | 22 | |
| 18 | 2019 | 18 | |
| 19 | 2020 | 17 | |
| 20 | 2020 | 16 |
About Mark McMillan
Mark McMillan is a scholar working on Microbiology, Epidemiology, Health, Infectious Diseases and Public Health, Environmental and Occupational Health, having authored 47 papers that have together received 1.2k indexed citations. Recurring topics across this work include Bacterial Infections and Vaccines (24 papers), Influenza Virus Research Studies (10 papers), Vaccine Coverage and Hesitancy (7 papers), Respiratory viral infections research (5 papers), Pneumonia and Respiratory Infections (3 papers), Pharmaceutical Practices and Patient Outcomes (1 paper), Hepatitis C virus research (1 paper) and SARS-CoV-2 detection and testing (1 paper). The work is most often cited by research in Microbiology (449 citations), Health (164 citations), Obstetrics and Gynecology (113 citations), Epidemiology (493 citations) and Applied Microbiology and Biotechnology (23 citations). Mark McMillan has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Helen Marshall, Debbie Kralik, Kylie Porritt, Thomas Sullivan, Ross Andrews, Bing Wang, Joshua S. Davis, Nicholas M. Anstey, Ann P. Koehler and Hassen Mohammed. Their work appears in journals such as Human Vaccines & Immunotherapeutics, Vaccine, Clinical Infectious Diseases, BMJ Open and Journal of Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.